EUVIMEDEUVIMED entdecken
Korrektur

Correction to “Endplate Chondrocyte Derived Exosomal miR-133a-3p Alleviates Intervertebral Disc Degeneration by Targeting the NF-κB Signaling Pathway through the miR-133a-3p/MAML1 Axis”

Qiuwei Li iD, Ruocheng Guo, Chenhao Zhao, Xuewu Chen, Hong Wang, Cailiang Shen

Molecular Pharmaceutics · 04.05.2026 · 23 (5) · 3235-3236

DOI: 10.1021/acs.molpharmaceut.6c00351 ↗

Kurz gefasst

Korrektur in der Zeitschrift Molecular Pharmaceutics, online erschienen am 31.03.2026. Verfasst von Qiuwei Li und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

ORCID-Profile: Qiuwei Li

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, Q., Guo, R., Zhao, C., Chen, X., Wang, H., & Shen, C. (2026). Correction to “Endplate Chondrocyte Derived Exosomal miR-133a-3p Alleviates Intervertebral Disc Degeneration by Targeting the NF-κB Signaling Pathway through the miR-133a-3p/MAML1 Axis”. Molecular Pharmaceutics, 23(5), 3235-3236. https://doi.org/10.1021/acs.molpharmaceut.6c00351

Vancouver

Li Q, Guo R, Zhao C, Chen X, Wang H, Shen C. Correction to “Endplate Chondrocyte Derived Exosomal miR-133a-3p Alleviates Intervertebral Disc Degeneration by Targeting the NF-κB Signaling Pathway through the miR-133a-3p/MAML1 Axis”. Molecular Pharmaceutics. 2026;23(5):3235-3236. doi:10.1021/acs.molpharmaceut.6c00351

BibTeX
@article{Li2026,
  author = {Li, Qiuwei and Guo, Ruocheng and Zhao, Chenhao and Chen, Xuewu and Wang, Hong and Shen, Cailiang},
  title = {Correction to “Endplate Chondrocyte Derived Exosomal miR-133a-3p Alleviates Intervertebral Disc Degeneration by Targeting the NF-κB Signaling Pathway through the miR-133a-3p/MAML1 Axis”},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {5},
  pages = {3235--3236},
  doi = {10.1021/acs.molpharmaceut.6c00351}
}
Kostenlos starten →